Extendicare (TSE:EXE) Hits New 12-Month High – Should You Buy?

Extendicare Inc. (TSE:EXE)’s stock price hit a new 52-week high on Monday . The stock traded as high as C$25.26 and last traded at C$24.85, with a volume of 77178 shares. The stock had previously closed at C$24.55.

Analyst Upgrades and Downgrades

EXE has been the topic of several research analyst reports. Canadian Imperial Bank of Commerce lifted their price target on shares of Extendicare from C$18.00 to C$22.00 in a research note on Thursday, November 13th. National Bank Financial boosted their target price on Extendicare from C$24.50 to C$29.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Cormark raised their price target on Extendicare from C$25.00 to C$30.00 in a research note on Wednesday, December 3rd. Canaccord Genuity Group boosted their price objective on Extendicare from C$20.00 to C$22.50 in a research note on Thursday, December 4th. Finally, Royal Bank Of Canada upgraded shares of Extendicare from a “hold” rating to a “moderate buy” rating and raised their target price for the stock from C$15.00 to C$25.00 in a research report on Thursday, December 4th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, Extendicare has an average rating of “Buy” and a consensus target price of C$24.50.

Extendicare Price Performance

The company has a current ratio of 0.62, a quick ratio of 0.98 and a debt-to-equity ratio of 283.02. The stock has a fifty day simple moving average of C$22.95 and a two-hundred day simple moving average of C$18.60. The company has a market cap of C$2.31 billion, a PE ratio of 23.10 and a beta of 1.30.

Extendicare Company Profile

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.